Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
  • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
  • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
  • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/60—Organic compounds having low molecular weight
  • H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
  • H10K85/636—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
  • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
  • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
  • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
  • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K50/00—Organic light-emitting devices
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/60—Organic compounds having low molecular weight
  • H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/60—Organic compounds having low molecular weight
  • H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/60—Organic compounds having low molecular weight
  • H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
  • H10K85/633—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/60—Organic compounds having low molecular weight
  • H10K85/649—Aromatic compounds comprising a hetero atom
  • H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
  • H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K2101/00—Properties of the organic materials covered by group H10K85/00
  • H10K2101/10—Triplet emission
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K50/00—Organic light-emitting devices
  • H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
  • H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K50/00—Organic light-emitting devices
  • H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
  • H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
  • H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/10—Organic polymers or oligomers
  • H10K85/111—Organic polymers or oligomers comprising aromatic, heteroaromatic, or aryl chains, e.g. polyaniline, polyphenylene or polyphenylene vinylene
  • H10K85/113—Heteroaromatic compounds comprising sulfur or selene, e.g. polythiophene
  • H10K85/1135—Polyethylene dioxythiophene [PEDOT]; Derivatives thereof
• • H—ELECTRICITY
  • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
  • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
  • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
  • H10K85/30—Coordination compounds
  • H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
  • H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium

Definitions

• the embodiments relate to host compounds for light-emitting layers in devices.
• OLEDs Organic light-emitting devices
• OLEDs may include an emissive or light-emitting layer that includes a host material and a light-emitting component dispersed within the host material.
• Host materials in OLEDs may have problems with low stability, a high charge-injection barrier, and imbalanced charge injection and mobility. These potential deficiencies with host materials may contribute to low efficiency and short lifetime of the devices comprising the host materials.
• Some embodiments include a compound represented by Formula 1 : (Formula 1)
• Cy 1 , Cy 2 , Cy 3 , Cy 4 , and Cy 5 are independently optionally substituted p-phenylene; Cy 6 is optionally substituted phenyl; Cy is optionally substituted phenyl or optionally substituted naphthalenyl, wherein Cy 6 and Cy 7 optionally link together to form a third ring comprising the N to which they are attached; and Cy is optionally substituted l-phenyl-lH-benzo[d]imidazol-2-yl.
• Cy 1 , Cy 2 , Cy 3 , Cy 4 , and Cy 5 are independently p-phenylene optionally substituted with 1 or 2 substituents independently selected from Ci_ 6 alkyl and F; Cy 6 is phenyl optionally substituted with 1, 2, or 3 substituents independently selected from C 1-6 alkyl and F; Cy is naphthalen-l-yl optionally substituted with 1, 2, or 3 substituents independently selected from Ci_ 6 alkyl and F; and Cy is 1-phenyl-lH- benzo[d]imidazol-2-yl optionally substituted with 1, 2, 3, 4, or 5 substituents independently selected from Ci_ 6 alkyl and F.
• Some embodiments include optionally substituted penta(para-phenylenyl) compounds, including optionally substituted l-(l-phenyl-lH-benzo[d]imidazol-2-yl)-[4 e - phenyl(naphthalen-l-yl)amino]penta(para-phenylenyl); optionally substituted 1 -(1 -phenyl- 1H- benzo[d]imidazol-2-yl)-[4 e -(carbazol-9-yl)amino]penta(para-phenylenyl); optionally substituted 1 -( 1 -phenyl- 1 H-benzo [d] imidazol-2-yl)- [4 e -diphenylamino]penta(para-phenylenyl) ; optionally substituted 1 -( 1 -phenyl- 1 H-benzo [d] imidazol-2-yl)- [
• Some embodiments include a light-emitting device comprising a compound described herein.
• FIG. 1 is a schematic drawing of an embodiment of an OLED comprising a compound disclosed herein.
• FIG. 2 is an electroluminescent spectrum of a device comprising a compound disclosed herein.
• FIG. 3 is a plot of current density and luminance as a function of driving voltage for an embodiment of an OLED comprising a compound disclosed herein.
• FIG. 4 is a plot of current efficiency and power efficiency as a function of luminance for an embodiment of an OLED comprising a compound disclosed herein.
• a compound or chemical structural feature such as aryl when referred to as being “optionally substituted,” it is meant that the feature may have no substituent (i.e. be unsubstituted) or may have one or more substituents.
• a feature that is "substituted” has one or more substituents.
• substituted has the ordinary meaning known to one of ordinary skill in the art.
• the substituent may be an ordinary organic moiety known in the art, which may have a molecular weight (e.g.
• the substituent comprises: 0-30, 0-20, 0-10, or 0-5 carbon atoms; and 0-30, 0-20, 0-10, or 0-5 heteroatoms independently selected from: N, O, S, Si, F, CI, Br, or I; provided that the substituent comprises at least one atom selected from: C, N, O, S, Si, F, CI, Br, or I.
• substituents include, but are not limited to, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, heteroaryl, hydroxy, alkoxy, aryloxy, acyl, acyloxy, alkylcarboxylate, thiol, alkylthio, cyano, halo, thiocarbonyl, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amido, N-amido, S-sulfonamido, N-sulfonamido, isocyanato, thiocyanato, isothiocyanato, nitro, silyl, sulfenyl, sulfinyl, sulfonyl, haloalkyl, haloalkoxyl, trihalomethanesulfonyl, trihalome
• a substituent may be a linking group that is attached to two or more structural features, e.g., a substituent can be a linking substituent so that Cy 1 , Cy 2 , and the linking substituent (e.g., alkyl, - 0-, -NH-, etc.) form a fused tricyclic ring system as described in greater detail herein.
• a substituent can be a linking substituent so that Cy 1 , Cy 2 , and the linking substituent (e.g., alkyl, - 0-, -NH-, etc.) form a fused tricyclic ring system as described in greater detail herein.
• naphthalen-2-yl 1 -phenyl- 1H- naphthalen-l-yl benzo [d] imidazol-2-yl
• alkyl has the ordinary meaning generally understood in the art, and may include a moiety composed of carbon and hydrogen containing no double or triple bonds.
• Alkyl may be linear alkyl, branched alkyl, cycloalkyl, or a combination thereof, and in some embodiments, may contain from one to thirty- five carbon atoms.
• alkyl may include Ci_io linear alkyl, such as methyl (-CH 3 ), ethyl (-CH 2 CH 3 ), n- propyl (-CH 2 CH 2 CH 3 ), n-butyl (-CH 2 CH 2 CH 2 CH 3 ), n-pentyl (-CH 2 CH 2 CH 2 CH 2 CH 3 ), n-hexyl (- CH 2 CH 2 CH 2 CH 2 CH 3 ), etc.; C 3 _i 0 branched alkyl, such as C 3 H 7 (e.g. iso-propyl), C 4 H 9 (e.g. branched butyl isomers), C 5 H 11 (e.g.
• C 6 Hi 3 e.g. branched hexyl isomers
• C 7 Hi 5 e.g. heptyl isomers
• C 3 _io cycloalkyl such as C 3 3 ⁇ 4 (e.g. cyclopropyl), C 4 H 7 (e.g. cyclobutyl isomers such as cyclobutyl, methylcyclopropyl, etc.), C 5 H 9 (e.g. cyclopentyl isomers such as cyclopentyl, methylcyclobutyl, dimethylcyclopropyl, etc.)
• C 6 Hii e.g.
• alkyl may be a linking group that is attached to two or more structural features, e.g., alkyl may be a linking substituent so that Cy 1 , Cy 2 , and the linking substituent form a fused tricyclic ring system as described in greater detail below.
• alkoxy includes -O-alkyl, such as -OCH 3 , - OC 2 H 5 , -OC 3 H 7 (e.g. propoxy isomers such as isopropoxy, n-propoxy, etc.), -OC 4 H 9 (e.g. butyoxy isomers), -OC 5 H 11 (e.g. pentoxy isomers), -OC 6 H 13 (e.g. hexoxy isomers), -OC 7 H 15 (e.g. heptoxy isomers), etc.
• -OCH 3 e.g. propoxy isomers such as isopropoxy, n-propoxy, etc.
• -OC 4 H 9 e.g. butyoxy isomers
• -OC 5 H 11 e.g. pentoxy isomers
• -OC 6 H 13 e.g. hexoxy isomers
• -OC 7 H 15 e.g. heptoxy isomers
• Formula 1 includes compounds such as those depicted by Formulas 2-24.
• Cyl, Cy2, Cy3, Cy4, and Cy5 may independently be optionally substituted p-phenylene.
• p-phenylene may have 1, 2, 3, or 4 substituents.
• some or all of the substituents on the p-phenylene may have: from 0 to 10 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• the substituents may be Cl-10 alkyl, such as CH3, C2H5, C3H7, cyclic C3H5, C4H9, cyclic C4H7, C5H11, cyclic C5H9, C6H13, cyclic C6H11, etc.; Cl- 10 alkoxy; halo, such as F, CI, Br, I; OH; CN; N02; Cl-6 fluoroalkyl, such as CF3, CF2H, C2F5, etc.; a Cl-10 ester such as -02CCH3, -C02CH3, -02CC2H5, -C02C2H5, -02C-phenyl, -C02-phenyl, etc.; a Cl-10 ketone such as -COCH3, -COC2H5, -COC3H7, -CO-phenyl, etc.; or a Cl-10 amine such as NH2, NH(CH3), N(CH3)2, N(CH3)
• Cy may be:
• Cy 1 is unsubstituted.
• Cy 2 may be:
• Cy 2 is unsubstituted.
• Cy 1 and Cy 2 are unsubstituted.
• Cy 1 and Cy 2 may share a linking substituent so that
• Cy 1 , Cy2 , and the linking substituent form a fused tricyclic ring system.
• -Cy 1 -Cy2 - may be:
• X may be any substituent that links Cy 1 to Cy2. In some embodiments, the substituent that that links Cy 1 to
• Cy may have: from 0 to 15 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• X may be:
• Cy 3 may be:
• Cy 3 is unsubstituted.
• Cy 2 and Cy 3 may share a linking substituent so that
• Cy 2 , Cy 3 , and the linking substituent form a fused tricyclic ring system.
• -Cy 2 -Cy 3 - may be:
• X 2 may be any substituent that links Cy 2 to Cy 3.
• the substituent that that links Cy 2 to Cy may have: from 0 to 15 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• X 2 may be:
• Cy may be:
• Cy 4 is unsubstituted.
• Cy 3 and Cy 4 may share a linking substituent so that
• Cy 3 , Cy 4 , and the linking substituent form a fused tricyclic ring system.
• -Cy 3 -Cy 4 - may be:
• X 3 may be any substituent that links Cy 3 to Cy 4.
• the substituent that that links Cy 3 to Cy 4 may have: from 0 to 15 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• X 3 may be:
• Cy 5 may be:
• Cy 5 is unsubstituted.
• Cy 4 and Cy 5 may share a linking substituent so that Cy 4 , Cy 5 , and the linking substituent form a fused tricyclic ring system.
• -Cy 4 -Cy 5 - may be:
• X may be any substituent that links Cy 4 to Cy 5 .
• the substituent that that links Cy 4 to Cy 5 may have: from 0 to 15 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• X 4 may be:
• X 4 may be
• Cy 6 may be optionally substituted phenyl.
• the phenyl if the phenyl is substituted, it may have 1, 2, 3, 4, or 5 substituents. Any substituent may be included on the phenyl.
• some or all of the substituents on the phenyl may have: from 0 to 15 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• the substituents may be Ci_io alkyl, such as CH 3 , C 2 H 5 , C 3 H 7 , cyclic C 3 3 ⁇ 4, C4H9, cyclic C 4 H 7 , C5H11, cyclic C5H9, C 6 Hi 3 , cyclic CeHii, etc.; Ci-10 alkoxy; halo, such as F, CI, Br, I; OH; CN; N0 2 ; Ci_6 fluoroalkyl, such as CF 3 , CF 2 H, C 2 F 5 , etc.; a C M0 ester such as -0 2 CCH 3 , -C0 2 CH 3 , -0 2 CC 2 H 5 , -C0 2 C 2 H 5 , -0 2 C-phenyl, -C0 2 -phenyl, etc.; a Ci-10 ketone such as -COCH 3 , -COC 2 H5, -COC 3 H 7 ,
• Cy 6 may be:
• Cy 7 may be optionally substituted phenyl or optionally substituted naphthalenyl, wherein Cy 6 and Cy 7 may optionally link together to form a fused tricyclic ring system comprising N.
• the phenyl if the phenyl is substituted, it may have 1, 2, 3, 4, or 5 substituents.
• if the naphthalenyl is substituted it may have 1, 2, 3, 4, 5, 6, or 7 substituents. Any substituent may be included on the phenyl or the naphthalenyl.
• some or all of the substituents on the phenyl or the naphthalenyl may have: from 0 to 15 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• the substituents may be Ci_io alkyl, such as CH 3 , C 2 H 5 , C 3 H 7 , cyclic C 3 H 5 , C 4 H 9 , cyclic C 4 H 7 , C 5 Hn, cyclic C 5 H 9 , C 6 Hi 3 , cyclic C 6 Hii, etc.; Ci_io alkoxy; halo, such as F, CI, Br, I; OH; CN; N0 2 ; Ci_ 6 fluoroalkyl, such as CF 3 , CF 2 H, C 2 F 5 , etc.; a C M0 ester such as -0 2 CCH 3 , -C0 2 CH 3 , -0 2 CC 2 H 5 , -C0 2 C 2 H 5 , -0 2 C- phenyl, -C0 2 -phenyl, etc.; a Ci_io ketone such as -COCH 3 , -COC 2 Hs, etc.
• Cy 7 may be:
• Cy 8 may be optionally substituted l-phenyl-lH-benzo[d]imidazol-2-yl.
• the 1- phenyl-lH-benzo[d]imidazol-2-yl if the 1- phenyl-lH-benzo[d]imidazol-2-yl is substituted, it may have 1, 2, 3, 4, 5, 6, 7, 8, or 9 substituents. Any substituent may be included.
• some or all of the substituents on the phenyl may have: from 0 to 10 carbon atoms and from 0 to 10 heteroatoms independently selected from: O, N, S, F, CI, Br, and I; and/or a molecular weight of 15 g/mol to 500 g/mol.
• the substituents may be Ci_io alkyl, such as CH 3 , C 2 H 5 , C 3 H 7 , cyclic C 3 H 5 , C 4 H 9 , cyclic C 4 H 7 , C 5 H 11 , cyclic C 5 H 9 , C 6 Hi 3 , cyclic C 6 Hii, etc.; Ci_i 0 alkoxy; halo, such as F, CI, Br, I; OH; CN; N0 2 ; Ci_6 fluoroalkyl, such as CF 3 , CF 2 H, C 2 F 5 , etc.; a Ci- 10 ester such as -0 2 CCH 3 , -C0 2 CH 3 , -0 2 CC 2 H 5 , -C0 2 C 2 H 5 , -0 2 C-phenyl, -C0 2 -phenyl, etc.; a C M0 ketone such as -COCH 3 , -COC 2 H 5 .
• each R A may independently be H; phenyl optionally substituted with 1, 2, 3, 4, or 5 substituents selected from: Ci_ 3 alkyl, halo, OH, or Ci_ 3 alkoxy; or C 1-12 alkyl, including: linear or branched alkyl having a formula C a H 2a+1 , wherein a is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, such as: CH 3 , C 2 3 ⁇ 4, C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 Hi 3 , C 7 Hi 5 , C 8 Hi 7 , C 9 H 19 , C 10 H 21 , etc., or cycloalkyl having a formula C b H 2b _i, wherein b is 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, such as: C 3 3 ⁇ 4, C 4 H 7 , C 5 H 9 , C 6 Hii, C 7 Hi 3 , C 8 Hi 5 ,
• each R B may independently be H; phenyl optionally substituted with 1, 2, 3, 4, or 5 substituents selected from: C 1-3 alkyl, halo, OH, or C 1-3 alkoxy; or C 1-12 alkyl, including: linear or branched alkyl having a formula C a H 2a+1 , wherein a is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, such as: CH 3 , C 2 3 ⁇ 4, C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 Hi 3 , C 7 Hi 5 , C 8 Hi 7 , C 9 H 19 , C 10 H 21 , etc., or cycloalkyl having a formula C b H 2b _i, wherein b is 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, such as: C 3 H 5 , C 4 H 7 , C 5 H 9 , C 6 Hii, C 7 Hi 3 , C 8 Hi 5 ,
• R 4 R 5 R 6 R 7 R 8 R 9 R 10 R 1 1 R 12 R 13 R 14 R 15 R 16 R 17 R 18 R 19 R 20 R 21 R 22 R 23 R 24 R 25 R 26 R 27 R 28 R 29 R 30 R 31 R 32 R 33 R 34 R 35 R 36 R 37 R 38 R 39 ⁇ R 41 ⁇ 1-41, ⁇ m&y independently be H or any substituent, such as a substituent having from 0 to 6 carbon atoms and from 0 to 5 heteroatoms independently selected from: O, N, S, F, CI, Br, and I, wherein the substituent has a molecular weight of 15 g/mol to 300 g/mol.
• R 1"41 may independently include R A , F, CI, CN, OR A , CF 3 , N0 2 , NR A R B , COR A , C0 2 R A , OCOR A , etc.
• any of R 1"41 may independently be H, Ci_ 6 alkyl, such as methyl, ethyl, propyl isomers, cyclopropyl, butyl isomers, cyclobutyl isomers, pentyl isomers, cyclopentyl isomers, hexyl isomers, cyclohexyl isomers, etc., or Ci_ 6 alkoxy, such as -O-methyl, -O-ethyl, isomers of -O-propyl, -O-cyclopropyl, isomers of -O-butyl, isomers of -O-cyclobutyl, isomers of -O-pentyl, isomers of -O-cyclopentyl, isomers of -O-hexyl, isomers of -O-cyclohexyl, etc.
• Ci_ 6 alkyl such as methyl, ethyl, propyl is
• any of R 1"41 may independently be H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments, any of R 1"41 may be H. In some embodiments, any of R 1"41 may independently be a linking group that is attached to two or more structural features, e.g., any of R 1"41 may be a linking substituent so that Cy 1 , Cy 2 , and the linking substituent form a fused tricyclic ring system as described in greater detail herein.
• R 1 , R 2 , R 3 , R 4 , and R 5 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 1 , R2 , R 3 , R 4 , and R 5 are H.
• R 1 , R 2 , R 4 , and R 5 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 1 , R 2 , R 4 , and R 5 are H.
• R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are H.
• R 12 are independently H, F, methyl, ethyl, propyl, or isopropyl.
• R 1 , R2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are H.
• R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 9 , and R 10 are independently H, F, methyl, ethyl, propyl, or isopropyl.
• R 1 , R2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 9 , and R 10 are H.
• R 13 , R 14 , R 15 , and R 16 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 13 , R 14 , R 15 , and R 16 are H
• R 17 , R 18 , R 19 , and R 20 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 17 , R 18 , R 19 , and R 20 are H
• R 21 , R 22 , R 23 , and R 24 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 21 , R 22 , R 23 , and R 24 are H.
• R 25 , R 26 , R 27 , and R 28 are independently H, F, methyl, ethyl, propyl, or isopropyl.
• R 25 , R 26 , R 2V , and R 28 are H.
• R 29 , R 30 , R 31 , and R 32 are independently H, F, methyl, ethyl, propyl, or isopropyl. In some embodiments R 29 , R 30 , R 31 , and R 32 are H.
• R 33 , R 34 , R 35 , R 36 , R 37 , R 38 , R 39 , R 40 , and R 41 are independently H, F, methyl, ethyl, propyl, or isopropyl.
• R 33 , R 34 , R 35 , R 36 , R 37 , R 38 , R 39 , R 40 , and R 41 are independently H, F, methyl, ethyl, propyl, or isopropyl.
• Some embodiments may include one of the compounds below:
• compositions comprising a compound of any one of Formulas 1-24 or any specific compound depicted or named herein (hereinafter referred to as "a subject compound").
• a composition comprising a subject compound may further comprise a fluorescent compound or a phosphorescent compound, and may be useful for light emission in devices such as organic light-emitting devices.
• an organic light-emitting device comprises a subject compound.
• light-emitting layer comprising a subject compound may is disposed between an anode and a cathode.
• the device is configured so that electrons can be transferred from the cathode to the light-emitting layer and holes can be transferred from the anode to the light-emitting layer.
• the subject compounds may have high photo stability and thermal stability in organic light-emitting devices.
• the subject compounds may also have well balanced hole and electron injection rates and mobilities. This may provide OLED devices with high efficiencies and/or long lifetimes.
• the subject compounds may also form amorphous solids, which may make the compounds easy to form into films.
• the anode may be a layer comprising a conventional material such as a metal, mixed metal, alloy, metal oxide or mixed-metal oxide, conductive polymer, and/or an inorganic material such as carbon nanotube (CNT). Examples of suitable metals include the Group 1 metals, the metals in Groups 4, 5, 6, and the Group 8-10 transition metals.
• the anode layer is to be light-transmitting, metals in Group 10 and 11, such as Au, Pt, and Ag, or alloys thereof; or mixed-metal oxides of Group 12, 13, and 14 metals, such as indium-tin-oxide ( ⁇ ), indium- zinc-oxide (IZO), and the like, may be used.
• the anode layer may be an organic material such as polyaniline. The use of polyaniline is described in “Flexible light- emitting diodes made from soluble conducting polymer," Nature, vol. 357, pp. 477-479 (11 June 1992).
• the anode layer can have a thickness in the range of about 1 nm to about 1000 nm.
• a cathode may be a layer including a material having a lower work function than the anode layer.
• suitable materials for the cathode layer include those selected from alkali metals of Group 1, Group 2 metals, Group 12 metals including rare earth elements, lanthanides and actinides, materials such as aluminum, indium, calcium, barium, samarium and magnesium, and combinations thereof.
• Li-containing organometallic compounds, LiF, and Li 2 0 may also be deposited between the organic layer and the cathode layer to lower the operating voltage.
• Suitable low work function metals include but are not limited to Al, Ag, Mg, Ca, Cu, Mg/Ag, LiF/Al, CsF, CsF/Al or alloys thereof.
• the cathode layer can have a thickness in the range of about 1 nm to about 1000 nm.
• a light-emitting layer may comprise a light-emitting component and a subject compound as a host.
• the amount of the host in a light-emitting layer may vary. In one embodiment, the amount of a host in a light-emitting layer is in the range of from about 1% to about 99.9% by weight of the light-emitting layer. In another embodiment, the amount of a host in a light-emitting layer is in the range of from about 90% to about 99% by weight of the light-emitting layer. In another embodiment, the amount of a host in a light- emitting layer is about 97% by weight of the light-emitting layer.
• the mass of the light-emitting component is about 0.1% to about 10%, about 1% to about 5%, or about 3% of the mass of the light-emitting layer.
• the light-emitting component may be a fluorescent and/or a phosphorescent compound.
• a light-emitting component may comprise an iridium coordination compound such as: bis- ⁇ 2-[3,5-bis(trifluoromethyl)phenyl]pyridinato-N,C2' ⁇ iridium(IJI)-picolinate; bis(2- [4,6-difluorophenyl]pyridinato-N,C2')iridium ( ⁇ ) picolinate; bis(2-[4,6- difluorophenyl]pyridinato-N,C2')iridium(acetylacetonate); Iridium ( ⁇ ) bis(4,6- difluorophenylpyridinato)-3-(trifluoromethyl)-5-(pyridine-2-yl)- 1 ,2,4-triazolate; Iridium bis(4,6-dif uorophenylpyridinato)-5-(pyridine-2-yl)-lH-tetrazolate; bis[2-(4,6- difluoropheny
• the thickness of a light-emitting layer may vary.
• a light- emitting layer has a thickness in the range of from about 1 nm to about 150 nm or about 200 nm.
• Some embodiments may have a structure as represented schematically by FIG. 1.
• a light-emitting layer 20 is disposed between an anode 5 and cathode 35.
• An optional electron-transport layer 30 may be disposed between the light-emitting layer 20 and the cathode 35.
• An optional hole-injection layer 10 may be disposed between the light-emitting layer 20 and the anode 5, and an optional hole-transport layer 15 may be disposed between the hole-injecting layer 10 and the light-emitting layer 20.
• a hole-transport layer may comprise at least one hole-transport material.
• Hole-transport materials may include, but are not limited to, an aromatic-substituted amine, a carbazole, a polyvinylcarbazole (PVK), e.g.
• a hole-injecting layer may comprise any suitable hole-injecting material.
• suitable hole-injecting material(s) include, but are not limited to, an optionally substituted compound selected from the following: molybdenum oxide (M0O 3 ), a polythiophene derivative such as poly(3,4-ethylenedioxythiophene (PEDOT)/polystyrene sulphonic acid (PSS), a benzidine derivative such as N, N, N', N'-tetraphenylbenzidine, poly(N,N'-bis(4-butylphenyl)- N,N'-bis(phenyl)benzidine), a triphenyl amine or phenylenediamine derivative such as N,N'-bis(4-methylphenyl)-N,N'-bis(phenyl)-l,4- phenylenediamine, 4,4',4"-tris(N-(naphthalen-2-yl)-N-phenyla
• An electron-transport layer may comprise at least one electron-transport material.
• electron-transport materials may include, but are not limited to, 2-(4- biphenylyl)-5-(4-tert-butylphenyl)-l,3,4-oxadiazole (PBD); l,3-bis(N,N-t-butyl-phenyl)-l,3,4- oxadiazole (OXD-7), l,3-bis[2-(2,2'-bipyridine-6-yl)-l,3,4-oxadiazo-5-yl]benzene; 3-phenyl-4- ( 1 ' -naphthalenyl)-5-phenyl- 1 ,2,4-triazole (TAZ) ; 2,9-dimethyl-4,7-diphenyl-phenanthroline (bathocuproine or BCP); aluminum tris(8-hydroxyquinolate) (Alq3); and l,3,5-tris(2-N- phenyl,
• the electron-transport layer is aluminum quinolate (Alq 3 ), 2-(4-biphenylyl)-5-(4-iert-butylphenyl)-l,3,4-oxadiazole (PBD), phenanthroline, quinoxaline, l,3,5-tris[N-phenylbenzimidazol-z-yl] benzene (TPBI), or a derivative or a combination thereof.
• additional layers may be included in the light-emitting device. These additional layers may include an electron injecting layer (EIL) between the cathode and the light-emitting layer, a hole-blocking layer (HBL) between the anode and the light-emitting layer, and/or an exciton-blocking layer (EBL) between the light-emitting layer and the anode and/or the cathode.
• EIL electron injecting layer
• HBL hole-blocking layer
• EBL exciton-blocking layer
• the light-emitting device can include an electron- injecting layer between the cathode layer and the light-emitting layer.
• suitable material(s) that can be included in the electron injecting layer include but are not limited to, an optionally substituted compound selected from the following: lithium fluoride (LiF), aluminum quinolate (Alq 3 ), 2-(4-biphenylyl)-5-(4-icri-butylphenyl)-l,3,4-oxadiazole (PBD), phenanthroline, quinoxaline, l,3,5-tris[N-phenylbenzimidazol-z-yl] benzene (TPBI) a triazine, a metal chelate of 8-hydroxyquinoline such as tris(8-hydroxyquinoliate) aluminum, and a metal thioxinoid compound such as bis(8-quinolinethiolato) zinc.
• LiF lithium fluoride
• Alq 3 aluminum quinolate
• PBD 2-(4-
• the electron injecting layer is aluminum quinolate (Alq 3 ), 2-(4-biphenylyl)-5-(4-te/t-butylphenyl)-l,3,4- oxadiazole (PBD), phenanthroline, quinoxaline, l,3,5-tris[N-phenylbenzimidazol-z-yl] benzene (TPBI), or a derivative or a combination thereof.
• the device can include a hole-blocking layer, e.g., between the cathode and the light-emitting layer.
• a hole-blocking layer e.g., between the cathode and the light-emitting layer.
• Various suitable hole-blocking materials that can be included in the hole-blocking layer are known to those skilled in the art.
• Suitable hole- blocking material(s) include but are not limited to, an optionally substituted compound selected from the following: bathocuproine (BCP), 3,4,5-triphenyl-l,2,4-triazole, 3,5-bis(4-tert-butyl- phenyl)-4-phenyl-[ 1,2,4] triazole, 2,9-dimethyl-4,7-diphenyl-l,10-phenanthroline, and l,l-bis(4- bis(4-methylphenyl)aminophenyl)-cyclohexane.
• BCP bathocuproine
• BCP bathocuproine
• 3,4,5-triphenyl-l,2,4-triazole 3,5-bis(4-tert-butyl- phenyl)-4-phenyl-[ 1,2,4] triazole
• 2,9-dimethyl-4,7-diphenyl-l,10-phenanthroline 2,9-dimethyl-4,7-diphenyl-l,
• the light-emitting device can include an exciton- blocking layer, e.g., between the light-emitting layer and the anode.
• the band gap of the material(s) that comprise exciton-blocking layer is large enough to substantially prevent the diffusion of excitons.
• suitable exciton-blocking materials that can be included in the exciton-blocking layer are known to those skilled in the art.
• Examples of material(s) that can compose an exciton-blocking layer include an optionally substituted compound selected from the following: aluminum quinolate (Alq 3 ), 4,4'-bis[N-(naphthalenyl)- N-phenyl-amino]biphenyl (a-NPD), 4,4'-N,N'-dicarbazole-biphenyl (CBP), and bathocuproine (BCP), and any other material(s) that have a large enough band gap to substantially prevent the diffusion of excitons.
• Alq 3 aluminum quinolate
• a-NPD 4,4'-bis[N-(naphthalenyl)- N-phenyl-amino]biphenyl
• CBP 4,4'-N,N'-dicarbazole-biphenyl
• BCP bathocuproine
• Light-emitting devices comprising a subject compound can be fabricated using techniques known in the art, as informed by the guidance provided herein.
• a glass substrate can be coated with a high work functioning metal such as ITO which can act as an anode.
• a light-emitting layer comprising a light-emitting component, can be deposited on the anode.
• additional optional layers such as a hole-transport layer, a hole-injecting layer, and/or an exciton-blocking layer may be deposited between the light-emitting layer and the anode, by methods such as vapor deposition, sputtering, or spin coating.
• the cathode layer comprising a low work functioning metal (e.g., Mg:Ag), can then be deposited on the light-emitting layer, e.g., by vapor deposition, sputtering, or spin coating.
• additional optional layers such as an electron-transport layer, an electron-injection layer, and/or an exciton-blocking layer, can be added to the device using suitable techniques such as vapor deposition, sputtering, or spin coating.
• a device comprising the subject compounds can provide a significantly increased device lifetime compared with commercially available compounds.
• the devices can provide a T50(h) @ 10000 nit lifetime of at least about 125 hours, 150 hours, 175 hours, 185 hours, and/or 200 hours.
• the desired lifetime can be determined by examining the luminescent/emissive decay of the device by measuring the luminescent, e.g., in cd/m , after applying a constant current of a 106 mA to device (corresponding to about 10000 cd/m ) for a device having an
• N-(4'-bromo- ⁇ 1.1 '-biphenyll -4- vD- N-phenylnaphthalen- 1 -amine (6) A mixture of N-phenylnaphthalen-1 -amine (4.41g, 20 mmol), 4,4'-dibromo- 1,1 '-biphenyl (15g, 48 mmol), sodium tert-butoxide (4.8g, 50 mmol) and Pd(dppf)Cl 2 (0.44 g, 0.6 mmol) in anhydrous toluene (100 ml) was degassed and heated at 80° C for 10 hours.
• Host-1 A mixture of compound 8 (1.50 g, 2.47 mmol), compound 5 (1.1 lg, 2.35 mmol), Pd(PPh 3 ) 4 (0.16g, 0.14 mmol) and potassium carbonate (1.38 g, 10 mmol) in dioxane/water (60 ml/10 ml) was degassed and heated at 85° C for 18 hours. After being cooled to RT, the mixture was filtered. The solid and the filtrate were collected separately.
• a device (Device A) was fabricated in a manner similar to the following.
• the ITO substrates having sheet resistance of about 14 ohm/sq were cleaned ultrasonically and sequentially in detergent, water, acetone, and then isopropyl alcohol (IPA); and then dried in an oven at 80 °C for about 30 min under an ambient environment.
• Substrates were then baked at about 200 °C for about 1 hour in an ambient environment, then under UV-ozone treatment for about 30 minutes.
• PEDOT:PSS hole-injection material
• the coated layer was then baked at about 100 °C for 30 min in an ambient environment, followed by baking at 200 °C for 30 min inside a glove box (N 2 environment).
• the substrate was then transferred into a vacuum chamber, where 4,4'- bis[N-(naphthalenyl)-N-phenyl-amino]biphenyl (NPB) was vacuum deposited at a rate of about 0.1 nm/s rate under a base pressure of about 2 x 10 " torr.
• TPBI l,3,5-Tris(l-phenyl-lH-benzimidazol-)2-yl)benzene
• the representative device structure was: rrO(about 150 nm thick)/PEDOT:PSS(about 30 nm thick)/NPB (about 40 nm thick)/Host-l: Ir(piq) 2 acac (about 30 nm thick)/TPBI(about 30nm thick)/LiF(about 0.5 nm thick)/Al(about 120 nm thick).
• the device was then encapsulated with a getter attached glass cap to cover the light- emitting area of the OLED device in order to protect from moisture, oxidation or mechanical damage.
• Each individual device had an area of about 13.2 mm 2 .
• Device A a light emitting device comprising Host-1: Ir(piq)2acac, and fabricated in accordance with Example 2.1, was tested to determine the lifetime of the devices (T5o(h) at 10,000 nit).
• Other devices Comparative Device X [Bebq2], and Comparative Device Y [CBP] were constructed in accordance to Example 2.1, except that, for the respective
• Table 2 shows the device lifetime of devices fabricated in accordance to Examples 2.2 and 2.3.
• Host-1 has demonstrated its effectiveness as a long lasting compound in light emitting organic light emitting devices.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Physics & Mathematics (AREA)
• Spectroscopy & Molecular Physics (AREA)
• Engineering & Computer Science (AREA)
• Materials Engineering (AREA)
• Optics & Photonics (AREA)
• Electroluminescent Light Sources (AREA)
• Plural Heterocyclic Compounds (AREA)

Priority Applications (4)

Applications Claiming Priority (2)

Publications (1)

Family

ID=44761411

Family Applications (1)

Country Status (6)

Families Citing this family (13)

Citations (1)

Family Cites Families (32)

• 2011
  • 2011-06-22 US US13/166,246 patent/US8933243B2/en not_active Expired - Fee Related
• 2012
  • 2012-06-21 JP JP2014517179A patent/JP6143748B2/ja not_active Expired - Fee Related
  • 2012-06-21 EP EP12731873.1A patent/EP2723721B1/en not_active Not-in-force
  • 2012-06-21 KR KR20137034890A patent/KR20140057500A/ko not_active Ceased
  • 2012-06-21 WO PCT/US2012/043595 patent/WO2012177914A1/en not_active Ceased
  • 2012-06-21 CN CN201280031055.8A patent/CN103635464B/zh not_active Expired - Fee Related
• 2014
  • 2014-12-12 US US14/569,333 patent/US9548458B2/en not_active Expired - Fee Related
• 2016
  • 2016-02-16 JP JP2016026856A patent/JP2016166177A/ja active Pending
• 2017
  • 2017-05-23 JP JP2017101839A patent/JP2017197548A/ja active Pending

Patent Citations (1)

Non-Patent Citations (3)

Also Published As

Similar Documents

Legal Events